The jab is taken once a week and can be administered at home in just 15 seconds, sparing users the need to visit a hospital.

An experimental Alzheimer's drug from Biogen, one with a novel approach, slowed decline at comparable rates as approved drugs in a mid-stage study.

The jab is taken once a week and can be administered at home in just 15 seconds, sparing users the need to visit a hospital.